Otix Global, Entropic: Volume Movers
Otix Global shares rallied after William Demant Holding said it will buy the hearing care company for $8.60 per share in a $50 million deal.
Separately, Otix Global said it will discontinue its German operations on Tuesday, adding that regulatory obstacles in Germany "have dramatically impacted the feasibility of stability of our business."
Shares of Otix Global surged by $4.31, or 106.7%, to $8.35. Volume topped 2.38 million shares, compared to the average daily share volume of only 12,000.Elsewhere, Entropic Communications (ENTR) jumped by 59 cents, or 6.9%, to $9.19 after the semiconductor company raised its third-quarter guidance. Entropic now expects third quarter revenue to range between $60 million and $61 million, up from its previous range of $51 million to $53 million. Volume topped 4.22 million shares, compared to the average daily share volume of 1.85 million. Opexa Therapeutics (OPXA) rallied by 69 cents, or 62.7%, to $1.79 after the biopharmaceutical company ahead of a presentation Tuesday at the Rodman & Renshaw Annual Healthcare Conference. Opexa's presentation, which will focus on the company's Tovaxin lead therapy for multiple sclerosis, will begin at 4:30 p.m. ET. Volume on Monday topped 1.67 million shares, compared to the average daily share volume of 65,000. -- Written by Robert Holmes in Boston.
>To contact the writer of this article, click here: Robert Holmes. >To follow Robert Holmes on Twitter, go to http://twitter.com/RobTheStreet. >To submit a news tip, send an email to: firstname.lastname@example.org.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV